Courage Therapeutics Inc

Think Therapeutics Inc., located in Newton, MA, specializes in leveraging machine learning technologies for vaccine design. The company is focused on advancing therapeutic solutions through innovative approaches in biotechnology. Founded in 2020, Think Therapeutics Inc. is dedicated to transforming the landscape of vaccine development. Their commitment to integrating cutting-edge technology aims to enhance the efficiency and effectiveness of vaccine design processes. Generated from the website

Captivate Bio LLC, located in Watertown, MA, specializes in providing high-quality products and services for the life sciences sector. Their extensive offerings include fetal bovine serum, human platelet lysate, custom media solutions, and a variety of reagents for diverse research areas such as cell culture and cellular agriculture. In addition to their product range, Captivate Bio offers tailored services like cell modeling and custom reagent sourcing to support scientific advancement. Their commitment to quality and innovation positions them as a valuable partner for researchers in cell therapy, vaccine development, and other critical fields within the life sciences industry. Generated from the website

Repligen Corporation develops novel therapeutics for the treatment of diseases of the central nervous and immune systems. It provides clinical development programs for the areas of schizophrenia, obsessive-compulsive disorder, bipolar disorder, multiple sclerosis and lupus. Repligen markets two niche products, Protein A and SecreFlo. Protein A is a consumable reagent used by the pharmaceutical industry to manufacture a class of drugs called monoclonal antibodies. The company offers a number of products based on recombinant Protein A, which include recombinant Protein A, Immobilized Protein A and Protein A ELISA Kits. SecreFlo is approved by the Food and Drug Administration to aid in the diagnosis of pancreatic exocrine dysfunction and gastrinoma and to aid in the identification and cannulation of the pancreatic ducts in patients undergoing endoscopic retrograde cholangiopancreatography. Repligen Corporation was established in 1981 and is headquartered in Waltham, Mass.